Peripersonal Space Representation in Upper Limb Segmental Exclusion

NCT ID: NCT07349173

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-15

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the representation of action peripersonal space (PPS) in subjects suffering from unilateral segmental exclusion syndrome of the upper limb compared to healthy control subjects. Segmental exclusion is defined by non-use or under-use of a limb segment without central nervous system damage. The study hypothesizes that this syndrome leads to a modification (shrinkage) of the PPS representation. Participants will perform reachability judgments in a Virtual Reality (VR) environment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Segmental exclusion syndrome often occurs after limb trauma and manifests as a neglect-like behavior of peripheral origin, sometimes associated with Complex Regional Pain Syndrome (CRPS). The study explores whether the lack of limb use affects the representation of peripersonal space (PPS)-the space immediately surrounding the body where interactions with objects occur.

The study is monocentric, observational, with a matched control group. Participants will undergo:

Clinical assessment (questionnaires on pain, anxiety, body perception, and kinesiophobia).

A Virtual Reality (VR) test (approx. 40 minutes). In VR, participants will judge whether a cylinder presented at different distances and angles is reachable without moving (Perceived Reachable Distance - DMA-p). This will be compared to their Real Reachable Distance (DMA-r).

The goal is to measure the error of judgment to assess PPS representation and check for correlations with body schema disturbances or functional impairment

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Segmental Exclusion Syndrome Complex Regional Pain Syndrome (CRPS) Upper Limb Neglect (Peripheral)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Exclusion

Patients presenting with unilateral segmental exclusion of the upper limb or part of the hand evolving for more than 3 months.

Reachability Judgment Task in VR.

Intervention Type BEHAVIORAL

Participants wear an Oculus Quest 2 VR headset. They first perform a motor task to measure Real Reachable Distance (DMA-r). Then, they perform a perceptual task where they must judge, without moving, if a virtual object is reachable (DMA-p). The test evaluates different spatial planes (front, 45° right, 45° left) and heights (shoulder, navel).

Healthy Controls

symptomatic volunteers with no history of upper limb impairment with sequelae.

Reachability Judgment Task in VR.

Intervention Type BEHAVIORAL

Participants wear an Oculus Quest 2 VR headset. They first perform a motor task to measure Real Reachable Distance (DMA-r). Then, they perform a perceptual task where they must judge, without moving, if a virtual object is reachable (DMA-p). The test evaluates different spatial planes (front, 45° right, 45° left) and heights (shoulder, navel).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reachability Judgment Task in VR.

Participants wear an Oculus Quest 2 VR headset. They first perform a motor task to measure Real Reachable Distance (DMA-r). Then, they perform a perceptual task where they must judge, without moving, if a virtual object is reachable (DMA-p). The test evaluates different spatial planes (front, 45° right, 45° left) and heights (shoulder, navel).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years.
* Presenting unilateral exclusion symptom of the upper limb or part of the hand evolving for \> 3 months.
* No contraindication to force work in daily activities.
* For patients with finger exclusion: at least 2 perturbed items related to exclusion on tests 3 and 4 of the "Bilan 400 points".
* Affiliated to a social security scheme.
* Able to understand simple orders.


* Age ≥ 18 years.
* No history of upper limb impairment with sequelae.

Exclusion Criteria

* Visual impairments.
* Central neurological pathology.
* Unstabilized psychiatric pathology.
* Communication or comprehension difficulties.
* Under legal protection or unable to consent.
* Pregnant or breastfeeding women.
* Cervical pathology contraindicating VR headset use.
* Epilepsy.
* Upper limb pathology unrelated to exclusion.
* Inability to stand for 40 minutes.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Régional de Médecine Physique et de Réadaptation (IRR), Centre Louis Pierquin.

Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amélie Touillet, MD

Role: CONTACT

+33 3 83 52 98 80

Jonahtan Pierret, PhD

Role: CONTACT

+33 3 83 52 67 61

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jonathan Pierret, PhD

Role: primary

+33 3 83 52 67 61

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A02189-40

Identifier Type: OTHER

Identifier Source: secondary_id

IRR-CLP-2023-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VR to Evaluate Phantom Limb Pain
NCT05915065 ACTIVE_NOT_RECRUITING NA